Wen‐Tsung Huang

Chi Mei Medical Center — Taiwan

Medicine · Health Sciences

19h-index1.8kcitations98works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(17), Colorectal Cancer Treatments and Studies(10), Lymphoma Diagnosis and Treatment(9), Lung Cancer Research Studies(9), Colorectal Cancer Surgical Treatments(6)

Publications98 total

Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy
Clinical Colorectal Cancer·2025
Treatment outcomes and safety of reduced‑dose venetoclax plus antifungal agents to treat acute myeloid leukemia: A single hospital experience in Taiwan
Oncology Letters·2025· 2 citedOpen Access
Glucokinase Regulatory Protein (GCKR) Links Metabolic Reprogramming With Immune Exclusion: Insights From a Pan‐Cancer Analysis and Gastric Cancer Validation
Human Mutation·2025Open Access
102P A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma after progression on first-line lenvatinib combined with PD-1 inhibitor
Immuno-Oncology Technology·2024· 1 citedOpen Access
A sarcopenia screening test predicts mortality among hospitalized cancer patients
Physiological Reports·2024· 2 citedOpen Access
Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta‐analysis
Journal of Gastroenterology and Hepatology·2024· 12 citedOpen Access
Age as a modifier of the effects of sarcopenia on survival among colon cancer patients after surgery
Journal of Surgical Oncology·2023· 3 citedOpen Access
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
The Lancet Oncology·2023· 177 citedOpen Access
Effects of Fracture Liaison Service on Outcomes of Patients with Hip Fracture in Rural Area of an Asian Country
Geriatric Orthopaedic Surgery & Rehabilitation·2023· 3 citedOpen Access
Anti-tumor activity of sunvozertinib in NSCLC with EGFR sensitizing mutations after failure of EGFR TKI treatment.
Journal of Clinical Oncology·2023· 5 cited
Supplementary Figure from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Data from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Supplementary Table from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Supplementary Table from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Supplementary Data from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Supplementary Data from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Data from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Supplementary Figure from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations
2023Open Access
Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis
Frontiers in Oncology·2023· 13 citedOpen Access
Incidence of second primary malignancies in women with different stages of breast cancer
Frontiers in Oncology·2023· 4 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Chao‐Jung Tsao(12), Wen‐Li Lin(8), Yin‐Hsun Feng(7), Shih‐Sung Chuang(7), Cheng-Yao Lin(6), Peihua Wu(5), Shu-Chan Chang(5), Sheng‐Tsung Chang(4), Jialing Sun(4), Shukui Qin(3), Ming‐Yang Lee(3), Yen‐Chuan Hsieh(3), Sheng‐Yen Hsiao(3), Wei‐Shou Hwang(3), Tsung‐Chih Tsai(3), Pasi A. Jänne(3), Wu‐Chou Su(3), James Chih‐Hsin Yang(3), How‐Ran Guo(3), Călin Cainap(2)